Choriogonadotropin alfa

DB00097ApprovedInvestigationalProtein Based TherapiesGonadotropinsGonadotropins and Antigonadotropins

Choriogonadotropin alfa is a recombinant form of human chorionic gonadotropin used to treat female infertility by inducing ovulation. Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132...

Protein structure of Choriogonadotropin alfa
Mechanism
Curator reviewed
Primary indication
For the treatment of female infertilityCurator reviewed · 3 structured indications
Formula / weight
C1105H1770N318O336S26 · 25719.7 Da
First approval
Canada, 2004 · United States, 1976 · European Union, 2016
Also known as
Choriogonadotropin alpha · Chorionic gonadotropin (recombinant)
Brand names
  • Ovidrel
  • Ovitrelle
  • Pregnyl

Resolves to

Compound
UNII6413W06WR3CAS177073-44-8ChEMBLCHEMBL1201464
Clinical / RWD
RxNorm283550ATCG03GA08PharmGKBPA164783947
Targets
P23945FSHRP22888LHCGR

What you can answer from here — as of July 17, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
4Drug interactionsStructured to mechanism, not free text
Sign in
51Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
7ContraindicationsEach with its own population and attribute set
Sign in
25Marketed productsAcross 7 countries and 11 labellers
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Choriogonadotropin alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In